Wolf Theiss has advised the Dr. Max Group on the acquisition of Gedeon Richter's pharma retail and wholesale operations in Romania. Filip & Company advised Gedeon Richter.
The transaction remains contingent on regulatory approval.
According to Wolf Theiss, “present in eight European countries, the Dr. Max Group is the leading pharmacy chain in Central Europe dedicated to improving the health of patients. In Romania, Dr. Max is present in over 750 pharmacies, offering access to a wide range of medicines and pharmaceutical services. The Dr. Max Group is fully owned by Penta Investments.”
Penta Investments is a Central European investment group established in 1994. It focuses on long-term investments in healthcare, financial services, manufacturing, retail, media, and real estate development.
According to Wolf Theiss, “Gedeon Richter is the largest producer of pharmaceuticals in Hungary. Gedeon Richter is also present in Romania, where it is the only vertically integrated pharma player on the local market, with manufacturing, distribution, and retail operations.”
The Wolf Theiss team included Partners Ileana Glodeanu and Anca Jurcovan, Senior Associates Mihai Coada, Luciana Tache, and Costin Salaru, and Associates Catalin Sabau, Nina Lazar, Maria Ionescu, and Claudia Andreescu.
Filip & Company's team included Partner Monica Statescu, Senior Associates Andreea Banica and Smaranda Vacaru, and Associate Andrei Anghel.
